BIONUTRICS ANNOUNCES FILING WITH THE SEC FOR A CHANGE OF NAME TO SYNOVICS PHARMACEUTICALS, INC.

Bionutrics, Inc., a specialty pharmaceutical company with proprietary drug formulation and delivery technologies utilized in the development of an extensive pipeline of difficult to formulate, oral controlled-release generic and branded drugs, announced today that on February 3, 2006 it filed a Preliminary Information Statement with the SEC for a name change to Synovics Pharmaceuticals, Inc. The Company has waited the requisite 10 days for comments from the SEC, of which it has received none.

Black Enterprise (http://www.blackenterprise.com/yb/ybopen.asp?section=ybbf&story_id=90257774&ID=blackenterprise)